Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 12/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | EIF4A1 | P60842 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914327 | 0.91 | ALDH1A1 (0.40) | SLC6A4SLC6A2SLC6A3KDM1A | |
| SCHEMBL23914259 | 0.88 | SLC6A4 (0.39) | SLC6A4SLC6A2SLC6A3KMT2AKDM1A | |
| SCHEMBL23913779 | 0.88 | SLC6A4 (0.39) | SLC6A4SLC6A2SLC6A3KMT2AKDM1A | |
| SCHEMBL23914311 | 0.88 | CTRB1 (0.35) | SLC6A4SLC6A2SLC6A3KMT2ARAB9A | |
| SCHEMBL23914312 | 0.88 | CTRB1 (0.35) | SLC6A4SLC6A2SLC6A3KMT2ARAB9A | |
| SCHEMBL23914260 | 0.84 | HDAC4 (0.39) | KMT2AMAOB | |
| SCHEMBL23914069 | 0.81 | ALDH1A1 (0.41) | SLC6A4SLC6A2SLC6A3CYP19A1KMT2A | |
| SCHEMBL23914420 | 0.81 | ALDH1A1 (0.41) | SLC6A4SLC6A2SLC6A3CYP19A1KMT2A | |
| SCHEMBL23914401 | 0.79 | ALDH1A1 (0.35) | SLC6A4SLC6A2SLC6A3KMT2AMAOB | |
| SCHEMBL23914440 | 0.76 | MAPT (0.42) | SLC6A4SLC6A2SLC6A3KMT2AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | SLC6A4 4444/4885SLC6A2 4850/4885SLC6A3 4632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.